ABC | Volume 113, Nº3, Setembro 2019

Artigo Original Kang et al. Pacientes com síndrome coronariana aguda Arq Bras Cardiol. 2019; 113(3):367-372 Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 10. Bertomeu V, Morillas P, Gonzalez-Juanatey JR, Quiles J, Guindo J , Soria F , et al. Prevalence and prognostic influence of peripheral arterial disease in patients>=40 years old admitted into hospital following an acute coronary event. Eur J Vasc Endovasc Surg. 2008;36(2):189-96. 11. Froehlich JB, Mukherjee D, Avezum A, Budaj A, Kline-Rogers EM, López- Sendón J,  et al. Association of peripheral artery disease with treatment and outcomes in acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). AmHeart J. 2006;151(5):1123-8. 12. Fowkes FG, Rudan D, Rudan I, Aboyans V , Denenberg JO, McDermott MM, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic reviewand analysis. Lancet. 2013; 382(9901):1329-40. 13. GunasekaranP , JeevananthamV , SharmaS, ThapaR, GuptaK . Implicationsof the 2013ACC/AHA cholesterol guidelines on contemporary clinical practice for patients with atherosclerotic coronary and peripheral arterial disease. Indian Heart J. 2017;69(4):464-8. 14. Amrock SM, Abraham CZ, Jung E, Morris PB, Shapiro MD . Risk Factors for Mortality Among IndividualsWith Peripheral Arterial Disease. Am J Cardiol. 2017;120(5):862-7. 15. Wattanakit K, Folosm AR, Selvin E, Weatherley BD, Pankow JS, Brancati FL,  et al. Risk factors for peripheral arterial disease incidence in person with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis. 2005;180(2):389-97. 16. Signorelli SS, Katsiki N. Oxidative stress and inflammation: their role in the pathogenesis of peripheral artery disease with or without type 2 diabetes mellitus. Curr Vasc Pharmacol. 2018;16(6):547-54. 17. Inglis SC, Bebchuk J, Al-Suhaim SA, Case J, Pfeffer MA, Solomon SD, et al. Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANT. Int J Cardiol. 2013;168(2):1094‑101. 372